EPISODE · Feb 10, 2021 · 10 MIN
Pod 204 - Understanding biosynthesis in the cannabis sector
from Business of Cannabis: Cannabis News | Cannabis Views | Cannabis Trends · host Mather Carscallen, Jay Rosenthal
On this episode of BofC Live, we connect with Dr. Mather Carscallen, the CEO and CTO of Algae-C – a plant biosynthesis company using algae to create plant-derived active pharmaceutical ingredients (APIs) – including cannabinoids. Carscallen describes the process of using algae for biosynthesis and the value it has to the cannabis sector – including cost, consistency and environmental impact.BofC Live is the daily news and interview program of Business of Cannabis. Business of Cannabis highlights the companies, brands, people and trends driving the sector.Learn more about Algae-C.
What this episode covers
On this episode of BofC Live, we connect with Dr. Mather Carscallen, the CEO and CTO of Algae-C – a plant biosynthesis company using algae to create plant-derived active pharmaceutical ingredients (APIs) – including cannabinoids. Carscallen describes the process of using algae for biosynthesis and the value it has to the cannabis sector – including cost, consistency and environmental impact.
NOW PLAYING
Pod 204 - Understanding biosynthesis in the cannabis sector
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m